Wang, Q. ; Sun, N. ; Zhang, C.-Y. ; Kunzke, T. ; Zens, P.* ; Feuchtinger, A. ; Berezowska, S.* ; Walch, A.K.
Metabolic heterogeneity in tumor cells impacts immunology in lung squamous cell carcinoma.
OncoImmunology 14:2457797 (2025)
Krombach, J.* ; Hennel, R.* ; Brix, N.* ; Orth, M.* ; Schoetz, U.* ; Ernst, A.* ; Schuster, J.* ; Zuchtriegel, G.* ; Reichel, C.A.* ; Bierschenk, S.* ; Sperandio, M.* ; Vogl, T.* ; Unkel, S.* ; Belka, C. ; Lauber, K.
Priming anti-tumor immunity by radiotherapy: Dying tumor cell-derived DAMPs trigger endothelial cell activation and recruitment of myeloid cells.
OncoImmunology 8:e1523097 (2019)
Lilis, I.* ; Ntaliarda, G.* ; Papaleonidopoulos, V.* ; Giotopoulou, G.A.* ; Oplopoiou, M.* ; Marazioti, A.* ; Spella, M.* ; Marwitz, S.* ; Goldmann, T.* ; Bravou, V.* ; Giopanou, I.* ; Stathopoulos, G.T.
Interleukin-1β provided by KIT-competent mast cells is required for KRAS-mutant lung adenocarcinoma.
OncoImmunology 8:1593802 (2019)
Liu, T.* ; Larionova, I.* ; Litviakov, N.* ; Riabov, V.* ; Zavyalova, M.V.* ; Tsyganov, M.* ; Buldakov, M.* ; Song, B.* ; Moganti, K.* ; Kazantseva, P.* ; Slonimskaya, E.* ; Kremmer, E. ; Flatley, A. ; Klüter, H.* ; Cherdyntseva, N.V.* ; Kzhyshkowska, J.*
Tumor-associated macrophages in human breast cancer produce new monocyte attracting and pro-angiogenic factor YKL-39 indicative for increased metastasis after neoadjuvant chemotherapy.
OncoImmunology 7:e1436922 (2018)
Giopanou, I.* ; Lilis, I.* ; Papaleonidopoulos, V.* ; Agalioti, T.* ; Kanellakis, N.I.* ; Spiropoulou, N.* ; Spella, M.* ; Stathopoulos, G.T.
Tumor-derived osteopontin isoforms cooperate with TRP53 and CCL2 to promote lung metastasis.
OncoImmunology 6:e1256528 (2017)
Bücklein, V.L. ; Adunka, T.* ; Mendler, A.N. ; Issels, R.D.* ; Subklewe, M. ; Schmollinger, J.C.* ; Nößner, E.
Progressive natural killer cell dysfunction associated with alterations in subset proportions and receptor expression in soft-tissue sarcoma patients.
OncoImmunology 5:e1178421 (2016)
Espinoza, J.A.* ; Jabeen, S.* ; Batra, R. ; Papaleo, E.* ; Haakensen, V.* ; Timmermans Wielenga, V.* ; Talman, M.L.M.* ; Brunner, N.* ; Børresen-Dale, A.L.* ; Gromov, P.* ; Helland, Å.* ; Kristensen, V.N.* ; Gromova, I.*
Cytokine profiling of tumor interstitial fluid of the breast and its relationship with lymphocyte infiltration and clinicopathological characteristics.
OncoImmunology 5:e1248015 (2016)
Schirmer, D.* ; Gruenewald, T.G.P.* ; Klar, R.* ; Schmidt, O.* ; Wohlleber, D.* ; Rubio, R.A.* ; Uckert, W.* ; Thiel, U.* ; Bohne, F. ; Busch, D.H.* ; Krackhardt, A.M.* ; Burdach, S.* ; Richter, G.H.S.*
Transgenic antigen-specific, HLA-A*02:01-allo-restricted cytotoxic T cells recognize tumor-associated target antigen STEAP1 with high specificity.
OncoImmunology 5:e1175795 (2016)
Toma, M.* ; Wehner, R.* ; Kloss, A.* ; Huebner, L.* ; Fodelianaki, G.* ; Erdmann, K.* ; Fuessel, S.* ; Zastrow, S.* ; Meinhardt, M.* ; Seliger, B.* ; Brech, D. ; Nößner, E. ; Tonn, T.* ; Schaekel, K.* ; Bornhaeuser, M.* ; Bachmann, M.P.* ; Wirth, M.P.* ; Baretton, G.* ; Schmitz, M.*
Accumulation of tolerogenic human 6-sulfo LacNAc dendritic cells in renal cell carcinoma is associated with poor prognosis.
OncoImmunology 4:e1008342 (2015)
Schendel, D.J. ; Frankenberger, B.
Limitations for TCR gene therapy by MHC-restricted fratricide and TCR-mediated hematopoietic stem cell toxicity.
OncoImmunology 2:e22410 (2013)
Weißbrich, B.* ; Nauerth, M.* ; Busch, D.H.
Adoptive immunotherapy: New assay for the identification of T cells with optimal avidity.
OncoImmunology 2:e26199 (2013)
Nößner, E. ; Brech, D. ; Mendler, A.N. ; Masouris, I. ; Schlenker, R. ; Prinz, P.U.
Intratumoral alterations of dendritic-cell differentiation and CD8+ T-cell energy are immune escape mechanisms of clear cell renal cell carcinoma.
OncoImmunology 1, 1451-1453 (2012)
Wilde, S. ; Schendel, D.J.
High-quality and high-avidity T cell clones specific for tumor-associated antigens and how to find them.
OncoImmunology 1, 1643-1644 (2012)
Wilde, S. ; Geiger, C. ; Milosevic, S. ; Mosetter, B. ; Eichenlaub, S. ; Schendel, D.J.
Generation of allo-restricted peptide-specific T cells using RNA-pulsed dendritic cells: A three phase experimental procedure.
OncoImmunology 1, 129-140 (2012)